Pharma News

Novartis
Novartis AG (NYSE: NVS) ("Novartis") today announced that its direct and indirect subsidiary, Novartis Groupe France S.A., a société anonyme organized under the laws of France ("Purchaser"), has commenced a cash tender offer to purchase all of the outstanding ordinary shares, nominal value EUR 0.10 per share, including Ordinary Shares [...]
Thu, Dec 07, 2017
Source Pharma News
Sanofi
Sanofi has launched two new late-stage clinical studies to determine if an investigational biologic called isatuximab, when used in combination with other commonly used cancer treatments, might be an effective treatment option for certain people with multiple myeloma, a rare blood cancer related to lymphoma and leukemia. [...]
Thu, Dec 07, 2017
Source Pharma News
A team of researchers led by the University of Minnesota has 3D printed lifelike artificial organ models that mimic the exact anatomical structure, mechanical properties, and look and feel of real organs. These patient-specific organ models, which include integrated soft sensors, can be used for practice surgeries to improve surgical [...]
Wed, Dec 06, 2017
Source Pharma News
Novo Nordisk
Today the International Diabetes Federation (IDF) presented the interim results of the first ever multi-country online survey on CVD risk awareness and knowledge among people living with type 2 diabetes, indicating low levels of awareness and limited dialogue between patients and healthcare professionals. The global survey - Taking Diabetes to [...]
Wed, Dec 06, 2017
Source Pharma News

(by Worldpharmanews)

Contact us
Dispopharm D&P Ltd.
Gewerbestrasse 18
4123 Allschwil
Switzerland
Phone: +41 61 487 96 36
Fax. +41 61 487 96 20
dispopharm@dispopharm.com
Dates
No dates at the moment.